Is Henry Meds legit and worth it?
Henry Meds is a real GLP-1 telehealth provider; we read its site and scored it 4.0/5 in our independent review (Strong Choice). Biggest plus: Unlimited telehealth visits included — no per-visit fees for ongoing support. Watch-out: No insurance accepted — full self-pay only.
Scorecard: strongest in Reputation (5.0/5) and Access (4.7/5); weakest in Trust & Transparency (3.5/5) and Support (3.5/5).
Medications
Compounded Semaglutide, Compounded Tirzepatide (as listed on its site, 7 April 2026)
Monthly Cost
$249-$399/mo (as listed on its site, 7 April 2026)
Speed to Start
Fast
Prices and medications in this review are as listed on Henry Meds’s site on 7 April 2026, unless a line is marked otherwise, and have not been re-checked since. Note added 13 October 2026.
Corrected 14 October 2026: this review previously gave a Better Business Bureau rating or listing status. We kept no record of where it came from, so it has been removed. Trustpilot figures in this review are as recorded in April 2026 and have not been re-checked.
About Henry Meds
Henry Meds has built a massive following in the compounded GLP-1 market, driven by strong patient satisfaction and a unique unlimited telehealth visits model that removes barriers to ongoing medical support. Founded in 2021 with roots in hormone therapy, the platform has expanded aggressively into GLP-1 weight loss.
The medication offerings include compounded semaglutide and compounded tirzepatide in both injectable and oral/sublingual formats — a delivery flexibility that many competitors lack. The oral/sublingual option is particularly appealing for patients who are needle-averse. Monthly pricing ranges from $249 to $399, placing Henry Meds in the mid-to-upper range for compounded medications.
Patient satisfaction metrics are outstanding: a 4.5 Trustpilot rating across 12,400+ reviews puts Henry Meds among the top-rated GLP-1 providers by review volume and quality. The unlimited telehealth visits model means patients can check in with providers as often as needed without additional consultation fees — a genuine value-add for patients who want more hands-on guidance.
It’s worth monitoring but may not reflect the typical patient experience.
Henry Meds operates as a compounded-only, self-pay platform with no insurance accepted. The clinical program is adequate (medium provider quality, medium support) but doesn’t include lab testing or dietitian access. For patients comfortable with the compounded model who value delivery format flexibility and unlimited provider access, Henry Meds delivers.
Henry Meds GLP-1 Medications
Screenshot of Henry Meds, captured by 10 April 2026
Screenshot of Henry Meds, captured by 10 April 2026
Screenshot of Henry Meds, captured by 10 April 2026
At a Glance
Medications Offered
Compounded Semaglutide, Compounded Tirzepatide (as listed on its site, 7 April 2026)
Both
Cost & Insurance
- Monthly: $249-$399/mo (as listed on its site, 7 April 2026)
- 6-month estimate: $1,494-$2,394 (as listed on its site, 7 April 2026)
- Insurance: No
- Self-pay: Yes
Clinical Features
- Lab testing: No
- Dietitian access: No
- Pharmacies named: None named on its own pages (read 7 and 8 October 2026); Henry Meds says its compounded medications “are prepared in accordance with Section 503A of the Federal Food, Drug, and Cosmetic Act and applicable state pharmacy laws”. Corrected 13 October 2026: this field previously listed Hallandale Pharmacy as a “reported partner”. We hold no source for that, so it has been removed.
Delivery & Access
- Format: Both (injectable + oral/sublingual)
- Nationwide telehealth: Yes
- Speed: Fast
- Spanish-speaking providers: Not stated Corrected 13 October 2026: this line said “Not available”, but our research had recorded it as unknown.
Start your GLP-1 weight loss journey with Henry Meds today
Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that should only be used under the supervision of a licensed healthcare provider. Individual results may vary.
Editorial Independence: GLP-1.Reviews maintains full editorial independence. We read providers’ own pages and public records and publish what we find, with the date we checked.
Corrected 13 October 2026: this review showed a “Verified Provider” badge and said our scores were “based on verified data and standardized criteria”. Neither described a check we had done, so both have been removed.
What the Henry Meds Intake Looks Like
We walked through Henry Meds’ GLP-1 weight-loss intake ourselves, from the opening goal question through provider review and subscription selection. Henry uses a “Provider Review” model where eligible patients don’t need a live video appointment — the provider reviews the written intake and messages approval through the portal.
Solid on the FDA black-box front — dedicated personal AND family history screens for both MEN-2 and medullary thyroid cancer, plus pancreatitis, pregnancy, and a current GLP-1 overlap check. Missing mental health, allergies, substance use, and broader comorbidity capture.
Low-moderate. About five minutes to complete, a free provider evaluation, and qualified patients don’t need a video appointment — provider review happens asynchronously. Card on file is required at checkout, but $0 is due unless the patient is prescribed.
The 9 Stages
Clinical Safety Screens Performed
Henry Meds’ defining feature is that qualified patients can skip the live video visit entirely. After completing the written intake, the eligibility screen reads: “Great news — you don’t need an appointment! You qualify for a Provider Review without a video call. Your healthcare provider will review your medical intake form and contact you with a personalized care plan, if medically eligible.” Patients who prefer a live conversation can still choose the video option for “more detailed questions” or “face-to-face support.” The trade-off is clear: faster, lower-friction access in exchange for a more structured and narrower set of screening questions — the written intake has to carry weight that a live clinician visit would otherwise cover.
Henry Meds is one of the platforms in our catalog that asks for family history — not just personal history — on both MEN-2 and medullary thyroid cancer. The questions explicitly define “family members” as “a parent, sibling, or child,” which matches how the FDA black-box warning language is phrased. Given that Henry’s default path is provider review without a live visit, this matters: the written intake is the only place to surface a family history risk factor, and Henry treats it as a hard gate rather than an afterthought.
Henry’s written intake is narrower than some catalog-wide peers. There is no validated PHQ-2 or PHQ-9 depression instrument or explicit mental-health question, no dedicated eating-disorder screen, no substance or alcohol screen, no structured allergy capture, and no broader comorbidity multi-select covering hypertension, sleep apnea, NAFLD, PCOS, or GERD. Diet and exercise history are not asked. There is no ID upload and no phone OTP. The provider review is the backstop for anything the written intake doesn’t capture.
Source: GLP-1.Reviews editorial walkthrough on April 13, 2026. We completed every screen of the Henry Meds weight-loss intake using a representative GLP-1 candidate persona and stopped before submitting any payment information.
Opens henrymeds.com in a new tab. We may earn a commission if you start treatment through this link, at no additional cost to you.
